Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Public ClinicalTrials.gov record NCT04091646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a parallel group, double blind, vehicle-controlled study assessed the safety and efficacy of roflumilast foam (ARQ-154) vs placebo foam in participants with seborrheic dermatitis.
Study identification
- NCT ID
- NCT04091646
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2019
- Primary completion
- Aug 17, 2020
- Completion
- Aug 20, 2020
- Last update posted
- Jul 2, 2023
2019 – 2020
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Biotherapeutics Clinical Site 19 | Fremont | California | 94538 | — |
| Arcutis Biotherapeutics Clinical Site 21 | Santa Monica | California | 90404 | — |
| Arcutis Biotherapeutics Clinical Site 42 | Coral Gables | Florida | 33134 | — |
| Arcutis Biotherapeutics Clinical Site 24 | Miami | Florida | 33144 | — |
| Arcutis Biotherapeutics Clinical Site 12 | Tampa | Florida | 33613 | — |
| Arcutis Biotherapeutics Clinical Site 10 | Rolling Meadows | Illinois | 60008 | — |
| Arcutis Biotherapeutics Clinical Site 22 | Plainfield | Indiana | 46168 | — |
| Arcutis Biotherapeutics Clinical Site 15 | Louisville | Kentucky | 40217 | — |
| Arcutis Biotherapeutics Clinical Site 28 | Rockville | Maryland | 20850 | — |
| Arcutis Biotherapeutics Clinical Site 40 | Clinton Township | Michigan | 48038 | — |
| Arcutis Biotherapeutics Clinical Site 20 | Detroit | Michigan | 48202 | — |
| Arcutis Biotherapeutics Clinical Site 14 | Fridley | Minnesota | 55432 | — |
| Arcutis Biotherapeutics Clinical Site 23 | High Point | North Carolina | 27262 | — |
| Arcutis Biotherapeutics Clinical Site 18 | Bexley | Ohio | 43209 | — |
| Arcutis Biotherapeutics Clinical Site 29 | Portland | Oregon | 97210 | — |
| Arcutis Biotherapeutics Clinical Site 27 | Pittsburgh | Pennsylvania | 15213 | — |
| Arcutis Biotherapeutics Clinical Site 13 | Arlington | Texas | 76011 | — |
| Arcutis Biotherapeutics Clinical Site 11 | Austin | Texas | 78759 | — |
| Arcutis Biotherapeutics Clinical Site 41 | College Station | Texas | 77845 | — |
| Arcutis Biotherapeutics Clinical Site 25 | Houston | Texas | 77056 | — |
| Arcutis Biotherapeutics Clinical Site 26 | Pflugerville | Texas | 78660 | — |
| Arcutis Biotherapeutics Clinical Site 17 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04091646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04091646 live on ClinicalTrials.gov.